Monday, October 27, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Biodesix chief commercial officer sells shares worth $644 By Investing.com

by Investing.com
November 13, 2024
in Business
Reading Time: 5 mins read
A A
0
Home Business
Share on FacebookShare on Twitter

Kieran O’Kane, the Chief Business Officer of Biodesix Inc. (NASDAQ:BDSX), not too long ago reported promoting firm inventory. Based on the SEC submitting, O’Kane offered a complete of 462 shares over two days. On November 11, he offered 238 shares at a median value of roughly $1.3909 per share, and on November 12, he offered 224 shares at a median value of about $1.4008 per share. The overall worth of those transactions amounted to $644.

These gross sales had been carried out to cowl taxes upon the vesting of Restricted Inventory Items (RSUs), as famous within the submitting. Following these transactions, O’Kane’s direct possession in Biodesix stands at 97,448 shares.

tags.

– Determine which info so as to add with the target of including worth and related info to the reader.

– Mimic the model of the article.

– Solely add info that’s associated to the article.

– Strive keep away from the phrases “Nonetheless, Regardless of, Moreover”. There isn’t any have to at all times current contradicting metrics. Give attention to metrics and ideas that will probably be most related to counterpoint the worth of the article.

– Write in a human method as potential, emulating the model of The Wall Road Journal and the article under.

– Select the metrics and ideas which are most related to the article. If potential, clarify why the following tips are associated to the article.

– All the time refer to those ideas as “InvestingPro Suggestions”

– When referencing ideas, subtly promote the InvestingPro product that features further ideas.

– Depend and record what number of further ideas are listed in InvestingPro as a method to promote the InvestingPro product.

– Data is supplied in USD.

– Do not embrace any hyperlinks or hyperlinks

– Simplify the information, particularly the date and timeframes supplied. For instance: don’t write LTM2023.Q1 however use a neater to grasp time period akin to “final twelve months as of Q1 2023”, and as an alternative of “FY2023.Q1” write “Q1 2023”.

VERY IMPORTANT Begin your response instantly with the headline, do not add any prefix textual content like “Okay, right here is your response:”, simply begin with the article instantly

InvestingPro Suggestions:

(Bear in mind to at all times refer to those ideas as “InvestingPro Suggestions” and a hyperlink a hyperlink to: https://www.investing.com/professional/TICKER (substitute TICKER with the corporate the article is written about, for instance: https://www.investing.com/professional/TSLA ))

BDSX

0. Rapidly burning by way of money

BDSX

1. Inventory has fared poorly over the past month

BDSX

2. Liquid property exceed quick time period obligations

BDSX

3. Not worthwhile over the past twelve months

BDSX

4. Buying and selling at a excessive Worth / Guide a number of

BDSX

5. Doesn’t pay a dividend to shareholders

InvestingPro Information:

Market Cap (Adjusted) -: 203.65M USD

BDSX

P/E Ratio -: -3.69

BDSX

P/E Ratio (Adjusted) LTM2024.Q3 -: -4.69

BDSX

PEG Ratio LTM2024.Q3 -: -0.08

BDSX

Worth / Guide LTM2024.Q3 -: 7.31

BDSX

Income LTM2024.Q3 -: 65.56M USD

BDSX

Income Development LTM2024.Q3 -: 48.92 %

BDSX

Income Development (Quarterly) FY2024.Q3 -: 34.54 %

BDSX

Gross Revenue LTM2024.Q3 -: 50.96M USD

BDSX

Gross Revenue Margin LTM2024.Q3 -: 77.72 %

BDSX

Working Earnings, Adjusted LTM2024.Q3 -: -34.56M USD

BDSX

Working Earnings Margin LTM2024.Q3 -: -52.71 %

BDSX

EBIT LTM2024.Q3 -: -34.56M USD

BDSX

EBITDA LTM2024.Q3 -: -29.26M USD

BDSX

EBITDA Development LTM2024.Q3 -: 35.11 %

BDSX

Fundamental EPS (Cont. Ops) LTM2024.Q3 -: -0.38 USD

BDSX

Diluted EPS (Cont. Ops) LTM2024.Q3 -: -0.38 USD

BDSX

Return on Property LTM2024.Q3 -: -46.24 %

BDSX

1 Week Worth Whole (EPA:) Return Y2024.D318 -: 5.26 %

BDSX

1 Month Worth Whole Return Y2024.D318 -: -17.16 %

BDSX

3 Month Worth Whole Return Y2024.D318 -: -18.6 %

BDSX

6 Month Worth Whole Return Y2024.D318 -: -7.89 %

BDSX

YTD Worth Whole Return Y2024.D318 -: -23.91 %

BDSX

1 12 months Worth Whole Return Y2024.D318 -: 7.69 %

BDSX

Worth % of 52 Week Excessive -: 63.35 %

BDSX

Worth, Earlier Shut -: 1.4 USD

BDSX

Common Each day Quantity (3m) Y2024.D318 -: 0.22M USD

BDSX

Subsequent (LON:) Earnings Date -: 2025-03-18

BDSX

Truthful Worth (Analyst Targets) Y2024.D318 -: 3 USD

BDSX

InvestingPro Truthful Worth -: 1.16 USD

VERY IMPORTANT Begin your response instantly with the headline, do not add any prefix textual content like “Okay, right here is your response:”, simply begin with the article instantly

Article to counterpoint:

Kieran O’Kane, the Chief Business Officer of Biodesix Inc. (NASDAQ:BDSX), not too long ago reported promoting firm inventory. Based on the SEC submitting, O’Kane offered a complete of 462 shares over two days. On November 11, he offered 238 shares at a median value of roughly $1.3909 per share, and on November 12, he offered 224 shares at a median value of about $1.4008 per share. The overall worth of those transactions amounted to $644.

These gross sales had been carried out to cowl taxes upon the vesting of Restricted Inventory Items (RSUs), as famous within the submitting. Following these transactions, O’Kane’s direct possession in Biodesix stands at 97,448 shares.

In different latest information, Biodesix, Inc., a distinguished participant in lung most cancers diagnostics, reported a sturdy efficiency in its third quarter of 2024 earnings name. The corporate introduced a 35% year-over-year improve in income, reaching $18.2 million, with lung diagnostic testing income climbing 40% to $17.2 million. Biodesix additionally improved its internet loss by 6% to $10.3 million whereas sustaining a gross margin of 78.4%.

Regardless of going through operational challenges as a consequence of hurricanes and delays in biopharma service tasks, the corporate reiterated its full-year income steering of $70 million to $72 million. Biodesix can be concentrating on an adjusted EBITDA breakeven within the second half of 2025.

When it comes to latest developments, the corporate launched new protection for Nodify assessments and offered vital information on the CHEST convention. Nonetheless, it is price noting that working bills rose to $22.6 million as a consequence of elevated gross sales and advertising efforts. The corporate ended the quarter with $31.4 million in money and introduced a brand new $50 million ATM program.

This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.





Source link

Tags: BiodesixchiefCommercialInvesting.comofficersellssharesWorth
Previous Post

There Might Be Monetary Dangers Below a Trump Presidency—Here is How you can Hedge In opposition to Them

Next Post

Dogecoin Worth To $20? Greater Montly Shut Suggests 8,000% Run Is Doable

Related Posts

BridgeBio Pharma, Inc. (BBIO) Discusses Positive FORTIFY Phase III Interim Results in Limb-Girdle Muscular Dystrophy Type 2I/R9 Transcript

BridgeBio Pharma, Inc. (BBIO) Discusses Positive FORTIFY Phase III Interim Results in Limb-Girdle Muscular Dystrophy Type 2I/R9 Transcript

by SA Transcripts
October 27, 2025
0

ObservePlay Earnings NamePlay Earnings Name BridgeBio Pharma, Inc. (NASDAQ:BBIO) Discusses Constructive FORTIFY Part III Interim Leads to Limb-Girdle Muscular Dystrophy...

Clean energy co Phinergy teams with Google and Microsoft

Clean energy co Phinergy teams with Google and Microsoft

by Boaz Bin-Nun
October 27, 2025
0

Clear vitality firm Phinergy (TASE: PNRG), a developer of fresh energy back-up primarily based on aluminium-air expertise, introduced this...

Peyush Bansal Explains How He Followed Radhakishan Damani For Success

Peyush Bansal Explains How He Followed Radhakishan Damani For Success

by Anas Ali
October 27, 2025
0

Damani's funding in Lenskart comes because the Softbank and Temasek-backed eyewear firm seems to boost Rs 2,150 crore by an...

Vodafone Idea shares fall 2.5% ahead of SC hearing today on AGR dues

Vodafone Idea shares fall 2.5% ahead of SC hearing today on AGR dues

by Euro Times
October 27, 2025
0

Vodafone Concept shares declined 2.49 per cent to ₹9.38 on Monday morning because the Supreme Court docket commenced listening to...

Dollar hits two-week high against yen as trade talks, Fed meeting loom

Dollar hits two-week high against yen as trade talks, Fed meeting loom

by Euro Times
October 27, 2025
0

The U.S. greenback rose to a greater than two-week excessive towards the yen on Monday in the beginning of a...

Partnership with Paramount boosts Taboola

Partnership with Paramount boosts Taboola

by Shiri Habib-Valdhorn
October 26, 2025
0

Taboola (Nasdaq: TBLA), which offers performance-based content material suggestions and promoting, rose by a cumulative 8.4% on Thursday and...

Next Post
Dogecoin Worth To ? Greater Montly Shut Suggests 8,000% Run Is Doable

Dogecoin Worth To $20? Greater Montly Shut Suggests 8,000% Run Is Doable

How to Get Double XP Tokens in Black Ops 6 and Warzone

How to Get Double XP Tokens in Black Ops 6 and Warzone

Stocks Rally to Record Highs on Favorable US CPI Report

Stocks Rally to Record Highs on Favorable US CPI Report

October 27, 2025
Federal investigators are looking into Tesla’s Mad Max mode, which reportedly defies speed limits

Federal investigators are looking into Tesla’s Mad Max mode, which reportedly defies speed limits

October 27, 2025
Tesla chair warns Musk may quit if trillion-dollar pay deal is rejected | Elon Musk News

Tesla chair warns Musk may quit if trillion-dollar pay deal is rejected | Elon Musk News

October 27, 2025
BridgeBio Pharma, Inc. (BBIO) Discusses Positive FORTIFY Phase III Interim Results in Limb-Girdle Muscular Dystrophy Type 2I/R9 Transcript

BridgeBio Pharma, Inc. (BBIO) Discusses Positive FORTIFY Phase III Interim Results in Limb-Girdle Muscular Dystrophy Type 2I/R9 Transcript

October 27, 2025
Galp Energia, SGPS, S.A. (GLPEY) Q3 2025 Earnings Call Transcript

Galp Energia, SGPS, S.A. (GLPEY) Q3 2025 Earnings Call Transcript

October 27, 2025
Peru to locally produce South Korean combat vehicles

Peru to locally produce South Korean combat vehicles

October 27, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Stocks Rally to Record Highs on Favorable US CPI Report

Federal investigators are looking into Tesla’s Mad Max mode, which reportedly defies speed limits

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In